Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Final Verdict: Research Comparison Feature Tirzepatide Retatrutide Receptor Targets GLP-1, GIP GLP-1, GIP, Glucagon Half-Life ~5 Days ~6 Days Max Published Weight Loss ~21% (72w) ~24% (48w) Liver Fat Reduction Moderate/High Extreme Primary Research Focus Glycemic Control Metabolic Reset / REE Future Outlook: Post-2025 Research Landscape As we look toward 2026 and beyond, the data from the Phase 3 TRIUMPH trials will likely solidify retatrutides position in the metabolic research hierarchy
Two of the most advanced medications available today are Semaglutide and Tirzepatide
The direct neurochemical effects on serotonin and dopamine systems mirror the mechanisms of established antidepressants
How It All Works Step 1: Schedule a consultation
Prefer Flexibility
US$ 24.91
US$ 25.85
US$ 28.04
